Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease: Reply to a rebuttal

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 4, 2011, Pages 889-890

  Grove, E L ^a   Hvas, A M ^a   Larsen, S B ^a   Mortensen, S B ^a   Kristensen, S D ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; RNA;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CORONARY ARTERY DISEASE; DRUG EFFECT; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; LETTER; PRIORITY JOURNAL; ST SEGMENT ELEVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE METABOLISM; THROMBOCYTE VOLUME; THROMBOCYTOPOIESIS;

EID: 79953296213     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04188.x     Document Type: Letter

References (12)

1. Ege MR, Zorlu A. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease: a rebuttal. J Thromb Haemost 2011; 9: 888.
2. Grove EL, Hvas AM, Mortensen SB, Larsen SB, Kristensen SD. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost 2011; 9: 185-91.
3. Guthikonda S, Lev EI, Patel R, DeLao T, Bergeron AL, Dong JF, Kleiman NS. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 2007; 5: 490-6.
4. Harrison P, Robinson MS, Mackie IJ, Machin SJ. Reticulated platelets. Platelets 1997; 8: 379-83.
5. Grove EL, Hvas AM, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Thromb Haemost 2009; 101: 151-6.
6. Wurtz M, Grove EL, Wulff LN, Kaltoft AK, Tilsted HH, Jensen LO, Hvas AM, Kristensen SD. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets. JACC Cardiovasc Interv 2010; 3: 828-35.
7. Brown AS, Martin JF. The megakaryocyte platelet system and vascular disease. Eur J Clin Invest 1994; 24(Suppl 1): 9-15.
8. Grove EL, Kristensen SD. Update on oral antiplatelet therapy: principles, problems and promises. Future Cardiol 2009; 5: 247-58.
9. Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J 2007; 154: 221-31.
10. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin 'resistance' and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008; 336: 195-8.
11. Perneby C, Wallen NH, Rooney C, Fitzgerald D, Hjemdahl P. Dose- and time-dependent antiplatelet effects of aspirin. Thromb Haemost 2006; 95: 652-8.
12. Henry P, Vermillet A, Boval B, Guyetand C, Petroni T, Dillinger JG, Sideris G, Bal Dit SC, Drouet L. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease. Thromb Haemost 2010; 105.